Macular degeneration is a leading cause of vision loss for people over 50, but there are ways to help protect your eyesight.

The global macular degeneration treatment market size was valued at USD 10.06 billion in 2024 and it is projected to reach ...

The Gonzales Lab at UNR Med, led by Albert Gonzales, Ph.D., assistant professor of physiology and cell biology, spearheaded ...

Introduction The eye's macula is impacted by macular degeneration, a neurodegenerative condition. Macular degeneration will cause loss of centr ...

DelveInsight's 'Dry Age-Related Macular Degeneration Pipeline Insight 2025' report provides comprehensive global coverage of ...

Age-related macular degeneration may cause a gradual reduction in your central vision over time, so you might not recognize AMD at first.

Discover the importance of vision, genetic eye disorders, and RNA-based therapies for precision treatment in India and ...

Apple Vision Pro brings relief to macular degeneration patients, with a daughter sharing how it improved her parent’s quality ...

Canaccord rates Opthea a buy with a $1.25 price target. But the broker thinks it could shoot as high as $3 if a key trial ...

Gene editing technique developed in Switzerland shows promise in curing Stargardt disease, a rare genetic eye disease causing ...

A new study has revealed that managing eye conditions through enhanced optometric services at local optometrists, rather than relying solely on hospital eye services (HES), can significantly reduce ...

Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that the US Patent Office (USPTO) has granted Active Biotech's US patent application 17/939,109 for laquinimod in eye disorders. "We ...